Content is for educational purposes and does not constitute medical or legal advice. Clinical decisions remain the responsibility of the prescriber.
Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the FDA. Statements have not been evaluated by the FDA. Availability and permissible compounding practices vary by state law.
Low-Dose Naltrexone: Small Dose, Big Conversation
Join Strive Pharmacy for a provider-focused educational session on low-dose naltrexone and its clinical applications.
Low-dose naltrexone (LDN) is increasingly used across autoimmune, inflammatory, metabolic, and chronic pain conditions, yet confusion around dosing and mechanism limits confident adoption.
In this session, we’ll review LDN’s clinical rationale, including endorphin modulation and TLR4 antagonism, and outline practical guidance for patient selection, titration, and monitoring to support responsible prescribing.
This webinar is designed for:
- Functional and integrative medicine providers
- Primary care providers
- Practitioners managing autoimmune or chronic inflammatory conditions
- Healthcare professionals exploring non-opioid therapeutic adjuncts
You’ll learn how to:
- Understand LDN’s mechanism of action and clinical rationale
- Differentiate standard-dose naltrexone from low-dose naltrexone
- Apply appropriate patient screening, dosing, and titration strategies
- Discuss potential benefits, limitations, and safety considerations
- And participate in a live Q&A with Strive experts
